47 completed, 23 terminated, 20 unknown, 16 recruiting. 126 Phase 2, 21 Phase 3, 11 Phase 1.
Follow Propranolol: new trials by email Literature Review of Propranolol trials Research Report on Propranolol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer Biospecimen Collection, Cholecalciferol, Computed Tomography - Advanced Hepatocellular Carcinoma, Advanced Melanoma | Phase 2 | Not yet recruiting | University of Southern California | 46 | 2026-11-01 | 2026-09-23 |
| Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence Propranolol, 120mg, Placebo - PTSD - Post Traumatic Stress Disorder | Phase 2 | Not yet recruiting | University Hospital, Tours | 34 | 2026-09-01 | 2026-03-05 |
| A Study of Propranolol to Treat Kaposi Sarcoma Propranolol - Kaposi Sarcoma | Phase 2 | Recruiting | AIDS Malignancy Consortium | 25 | 2026-08-31 | 2026-10-05 |
| Neoadjuvant Propranolol Plus SOX and Toripalimab for Locally Advanced Gastric/GEJ Adenocarcinoma propranolol, Toripalimab, Oxaliplatin - Gastric or Gastroesophageal Junction Adenocarcinoma, Propranolol | Phase 1 / Phase 2 | Not yet recruiting | Ting Liu | 49 | 2026-08-01 | 2026-07-27 |
| Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus CAPEOX and Propranolol for Locally Advanced pMMR Colon Cancer: A Prospective, Single-Center, Multi-Cohort Study Iparomlimab/Tuvonralimab, Capecitabine, Oxaliplatin - Colon Cancer (Stage II &Amp; III), Immunotherapy | Phase 2 | Not yet recruiting | Sun Yat-sen University | 45 | 2026-04-20 | 2026-04-24 |
| Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism Propranolol, Placebo - Autism Spectrum Disorder, Challenging Behaviour | Phase 2 | Recruiting | Jeremy Veenstra-vanderweele | 60 | 2026-01-30 | 2026-09-01 |
| Propranolol Treatment for Postoperative Chylothorax Propranolol Hydrochloride, Placebo - Postoperative Chylothorax, Congenital Heart Disease | Phase 1 / Phase 2 | Suspended | June Wu | 50 | 2025-09-09 | 2026-05-15 |
| Propranolol for the Treatment of Kaposi Sarcoma in Adults Propranolol Hydrochloride - Kaposi Sarcoma | Phase 2 | Recruiting | Washington University School of Medicine | 25 | 2025-08-20 | 2026-04-06 |
| Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer Propranolol Hydrochloride, Paclitaxel liposome, Carboplatin - Ovarian Cancer | Phase 2 | Recruiting | Bai-Rong Xia | 136 | 2025-06-20 | 2026-06-30 |
| Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression Propranolol (Beta-Blocker) and Etodolac (COX-2 Inhibitor), Placebo (Matching for Propranolol & Etodolac) - Ovarian Cancer, Ovarian Cancer Metastatic Recurrent | Phase 2 | Recruiting | Tel-Aviv Sourasky Medical Center | 60 | 2025-03-12 | 2025-07-11 |
| Evaluating the Impact of Adjuvant Use of Beta Blockers on Clinical Outcomes in Patients With Traumatic Brain Injury control, propranolol, Carvedilol - TBI Traumatic Brain Injury | Phase 1 / Phase 2 | Recruiting | Mansoura University | 100 | 2025-01-20 | 2025-04-02 |
| Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma propranolol - Infantile Hemangioma | Phase 2 / Phase 3 | Recruiting | West China Hospital | 32 | 2025-01-01 | 2026-11-12 |
| The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors propranolol (beta-blocker used treat high blood pressure) - Gastrointestinal Tumors | Phase 2 | Recruiting | Huashan Hospital | 40 | 2024-12-01 | 2025-01-14 |
| Efficacy of Traumatic Memory Modification Using Memory Reconsolidation and Propranolol Among Adolescents With PTSD Propranolol, Placebo - Post Traumatic Stress Disorder | Phase 2 | Withdrawn | Rennes University Hospital | 2024-10-01 | 2025-09-08 | |
| Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer Biopsy, Biospecimen Collection, Computed Tomography - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 2 | Recruiting | Emory University | 37 | 2024-09-01 | 2026-06-04 |
| Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. Propranolol, Placebo - Pancreatic Cancer, Surgery | Phase 2 | Recruiting | Zealand University Hospital | 30 | 2024-03-20 | 2024-03-28 |
| Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib Amivantamab IV, Amivantamab SC, Lazertinib - Carcinoma, Non-Small-Cell Lung | Phase 2 | Active not recruiting | Janssen Research & Development, LLC | 305 | 2024-02-16 | 2026-11-03 |
| Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder Propranolol, Placebo - Stress Disorders, Post-Traumatic, Alcohol Use Disorder | Phase 2 | Completed | Centre for Addiction and Mental Health | 48 | 2023-07-15 | 2026-06-15 |
| Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) Durvalumab, Gemcitabine, Nab paclitaxel - Pancreatic Cancer, Hepatocellular Cancer | Phase 2 | Active not recruiting | AHS Cancer Control Alberta | 15 | 2023-07-05 | 2026-11-04 |
| Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma Biopsy, Biospecimen Collection, Computed Tomography - Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Phase 2 | Recruiting | Roswell Park Cancer Institute | 40 | 2023-03-07 | 2025-12-16 |
Showing 20 of 126. Sign in to see all of them.
Stress Disorders, Post-Traumatic (13) · Burns (6) · Melanoma (5) · Retinopathy of Prematurity (5) · Brain Injuries, Traumatic (4) · Cocaine-Related Disorders (4) · Wounds and Injuries (4) · Adjustment Disorders (3) · Behavior, Addictive (3) · Hemangioma (3) · Hemangiosarcoma (3) · Hypertension, Portal (3) · Pancreatic Neoplasms (3) · Prostatic Neoplasms (3) · Stress Disorders, Traumatic, Acute (3)
Douglas Mental Health University Institute (5) · The University of Texas Medical Branch, Galveston (5) · Emory University (3) · Medical University of South Carolina (3) · Roswell Park Cancer Institute (3) · University of North Carolina, Chapel Hill (3) · Assaf-Harofeh Medical Center (2) · Columbia University (2) · Johns Hopkins University (2) · Meyer Children's Hospital IRCCS (2) · National Institute of Mental Health (NIMH) (2) · University Hospital, Toulouse (2) · University of Dundee (2) · Vicus Therapeutics (2) · AHS Cancer Control Alberta (1)
United States (56) · Canada (14) · China (8) · France (8) · Germany (5) · Brazil (4) · Israel (4) · Italy (4) · Norway (4) · Egypt (3) · Switzerland (3) · Taiwan (3) · Argentina (2) · Denmark (2) · Mexico (2)
David N Herndon, MD (4) · Alain Brunet, Ph.D. (2) · Brian J Lipworth, MD (2) · Oded Zmora, MD (2) · Ahmed Hassan, MD (1) · Ahmed T Ahmed, A professor (1) · Alain Brunet, PhD. (1) · Ana K Tamara, Physician (1) · Anna Blecher, Dr. (1) · Anu Sharma, MD (1) · Anurag Singh, MD (1) · Ashok Hemal (1) · Bai-Rong Xia, Doctor (1) · Barbie Zimmerman-Bier, M.D. (1)
PMID 22606232, PMID 42088573, PMID 15583741, PMID 15890495, PMID 15911704, PMID 15978266, PMID 16697124, PMID 18791359, PMID 19240154, PMID 19687359, PMID 19734776, PMID 20395554, PMID 20701787, PMID 20739853, PMID 20881067, PMID 21789167, PMID 22365565, PMID 22463890, PMID 22895351, PMID 23013802, PMID 23150682, PMID 23303450, PMID 23321647, PMID 23511841, PMID 23593932, PMID 24002370, PMID 24009246, PMID 24054431, PMID 24227635, PMID 24298851, PMID 24335848, PMID 24347141, PMID 24495468, PMID 24526257, PMID 24606242, PMID 24655871, PMID 24721800, PMID 24824900, PMID 24918945, PMID 24938324, PMID 25211297, PMID 25514427, PMID 25693013, PMID 25807408, PMID 25968340, PMID 26123421, PMID 26607848, PMID 27171844, PMID 27433905, PMID 28065396
2008 (2), 2017 (2), 2023 (2), P50GM060338 (2), 1RC1AA019019-01 (1), 2015 (1), K01HL096434 (1), K08CA279766 (1), K20DA000238 (1), P30CA012197 (1), P30CA014089 (1), P30CA138292 (1), P50DA012756 (1), R01AA022285 (1), R01GM056687 (1)